Your browser doesn't support javascript.
loading
Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
Iuchi, Toshihiko; Hatano, Kazuo; Kodama, Takashi; Sakaida, Tsukasa; Yokoi, Sana; Kawasaki, Koichiro; Hasegawa, Yuzo; Hara, Ryusuke.
Afiliação
  • Iuchi T; Division of Neurological Surgery, Chiba Cancer Center, Chiba, Japan. Electronic address: tiuchi@chiba-c.jp.
  • Hatano K; Division of Radiation Oncology, Chiba Cancer Center, Chiba, Japan.
  • Kodama T; Division of Radiation Oncology, Chiba Cancer Center, Chiba, Japan.
  • Sakaida T; Division of Neurological Surgery, Chiba Cancer Center, Chiba, Japan.
  • Yokoi S; Division of Gene Diagnosis, Chiba Cancer Center, Chiba, Japan.
  • Kawasaki K; Division of Neurological Surgery, Chiba Cancer Center, Chiba, Japan.
  • Hasegawa Y; Division of Neurological Surgery, Chiba Cancer Center, Chiba, Japan.
  • Hara R; Division of Radiation Oncology, Chiba Cancer Center, Chiba, Japan.
Int J Radiat Oncol Biol Phys ; 88(4): 793-800, 2014 Mar 15.
Article em En | MEDLINE | ID: mdl-24495592

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / Dacarbazina / Radioterapia de Intensidade Modulada Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / Dacarbazina / Radioterapia de Intensidade Modulada Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article